4D Lifetec secures CHF 23.3 million to enhance cancer diagnosis

4D Lifetec secures CHF 23.3 million to enhance cancer diagnosis

Along with its CHF 23.3 million investment in 4D Lifetec AG, Xlife Sciences AG has brought an AI software developed specifically for 4D Lifetec to massively expand the functionality of its 4D Lifetest in digital health. In exchange, the investor acquired a 20% stake in the company.

MORE

Leave a reply